Your browser doesn't support javascript.
loading
Quantification of sorafenib, lenvatinib, and apatinib in human plasma for therapeutic drug monitoring by UPLC-MS/MS.
Ye, Zhenjie; Wu, Lingjie; Zhang, Xiaoying; Hu, Yingying; Zheng, Ling.
Afiliación
  • Ye Z; Clinical Research Center for Phase I, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, 350025, PR China.
  • Wu L; Clinical Research Center for Phase I, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, 350025, PR China; The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, 350025, PR
  • Zhang X; Clinical Research Center for Phase I, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, 350025, PR China.
  • Hu Y; Department of Pharmacy, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, 350025, PR China. Electronic address: celiahyy@126.com.
  • Zheng L; Clinical Research Center for Phase I, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, 350025, PR China. Electronic address: zhengling_mc@163.com.
J Pharm Biomed Anal ; 202: 114161, 2021 Aug 05.
Article en En | MEDLINE | ID: mdl-34052550

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Preparaciones Farmacéuticas / Neoplasias Hepáticas Límite: Humans Idioma: En Revista: J Pharm Biomed Anal Año: 2021 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Preparaciones Farmacéuticas / Neoplasias Hepáticas Límite: Humans Idioma: En Revista: J Pharm Biomed Anal Año: 2021 Tipo del documento: Article Pais de publicación: Reino Unido